Clinical Trial Update: Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 [Phase 2]

View source ↗

Summary

Open-label extension study for patients previously enrolled in CIN-107-124 (Phase 2) has completed and results have been posted. The sponsor is AstraZeneca and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2024-12-16